Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Myeloid 1

Conditions

Leukemia, Myeloid, Acute 5Leukemia, Myelogenous, Chronic, BCR-ABL Positive 3Leukemia 3Leukemia, Myeloid, Chronic-Phase 2Myelodysplastic Syndromes 1Leukemia, Myelomonocytic, Acute 1Leukemia, Myeloid, Accelerated Phase 1Leukemia, Myeloid 1Leukemia, Monocytic, Acute 1Leukemia, Megakaryoblastic, Acute 1Leukemia, Erythroblastic, Acute 1Leukemia, Biphenotypic, Acute 1Hematologic Neoplasms 1Congenital Abnormalities 1Blast Crisis 1

Interventions

Cyclophosphamide 12fludarabine phosphate 11Peripheral Blood Stem Cell Transplantation 10Cyclosporine 9Antilymphocyte Serum 9Methotrexate 8Busulfan 8Tacrolimus 7Radiotherapy 7Whole-Body Irradiation 6Mycophenolic Acid 6Filgrastim 6Methylprednisolone 5Cord Blood Stem Cell Transplantation 5Sirolimus 4Melphalan 4Flow Cytometry 4Thiotepa 3Rituximab 3Imatinib Mesylate 3Dasatinib 3Sunitinib 2Moxifloxacin 2Leucovorin 2Immunosuppression Therapy 2Granulocyte Colony-Stimulating Factor 2Etoposide 2Cytarabine 2Bortezomib 2Amplified Fragment Length Polymorphism Analysis 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Terminated × Leukemia, Myeloid, Accelerated Phase × Homoharringtonine × Clear all
NCT00114959 2015-01-15

Homoharringtonine With Oral Gleevec in Chronic, Accelerated and Blast Phase Chronic Myeloid Leukemia (CML)

Teva Branded Pharmaceutical Products R&D, Inc.

Phase 2 Terminated
15 enrolled 6 charts
MyeloidOther hematologic neoplasm

Blast Crisis, Leukemia, Leukemia, Myeloid, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Accelerated Phase, Leukemia, Myeloid, Chronic-Phase

Data powered by HemOnc (CC BY 4.0) Colophon âš¡